📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
Sagility Q3 FY26 Revenue Surges 35.7% YoY to ₹19,712 Million; Adj. PAT Up 23%
Sagility Limited reported a robust Q3 FY26 with consolidated revenue growing 35.7% YoY to ₹19,712 million, supported by a 29.1% growth in constant currency terms. Adjusted EBITDA for the quarter rose 24.2% YoY to ₹5,125 million with a healthy margin of 26.0%. The company's Adjusted PAT for the nine-month period (9M FY26) showed a significant jump of 44.3% YoY, reaching ₹8,236 million. Notably, the company is successfully diversifying its revenue stream, with the top 10 clients' contribution decreasing from 90.5% in FY25 to 84.6% in the current trailing twelve months.
Key Highlights
Q3 Revenue at ₹19,712 million, up 35.7% YoY (29.1% in constant currency).
Adjusted PAT for Q3 grew 23.0% YoY to ₹3,229 million with a 16.4% margin.
9M FY26 Adjusted PAT increased by 44.3% YoY to ₹8,236 million.
Active client groups increased to 81 from 75 in FY25, reducing top-10 client concentration to 84.6%.
Employee headcount reached 48,522 across 35 delivery centers in 5 countries.
💼 Action for Investors
Investors should take note of the strong organic growth and successful integration of acquisitions like BroadPath which are driving top-line momentum. The improving client diversification and consistent margins make it a strong play in the U.S. healthcare outsourcing space.
Sagility Q3 FY26 Net Profit Rises 23.4% YoY to ₹2,676.5M; Revenue Up 35.6%
Sagility Limited reported a strong performance for the quarter ended December 31, 2025, with consolidated revenue growing 35.6% YoY to ₹19,711.53 million. Net profit for the quarter increased by 23.4% YoY to ₹2,676.56 million, despite an exceptional charge of ₹328.23 million related to the impact of new Labour Codes. The company maintained steady sequential growth with revenue up 18.8% compared to the previous quarter. Operating expenses, particularly employee benefits, rose to ₹12,191.58 million, reflecting the company's expansion and headcount requirements.
Key Highlights
Revenue from operations grew 35.6% YoY to ₹19,711.53 million from ₹14,530.69 million.
Consolidated Net Profit increased 23.4% YoY to ₹2,676.56 million compared to ₹2,169.14 million in Q3 FY25.
Reported an exceptional item of ₹328.23 million on account of the impact of new Labour Codes.
Nine-month (9M FY26) revenue reached ₹51,685.94 million, a significant jump from ₹40,014.42 million in 9M FY25.
Basic and Diluted EPS improved to ₹0.57 for the quarter from ₹0.46 in the year-ago period.
💼 Action for Investors
The company demonstrates robust top-line growth in the healthcare BPM sector; investors should monitor if margin compression from labor costs stabilizes. The stock remains a growth play in the specialized healthcare services outsourcing market.
Sagility Q3 FY26 Revenue Grows 35.7% YoY to ₹19,712 Mn; Adjusted PAT Up 23%
Sagility Limited delivered a robust Q3 FY26 performance with revenue rising 35.7% YoY to ₹19,712 million, supported by 19.9% organic growth. Adjusted EBITDA reached ₹5,125 million at a 26% margin, while 9M FY26 Adjusted PAT saw a significant 44.3% jump to ₹8,236 million. The company added 3 new clients and secured $30.5 million in new business ACV, though DSO increased to 86 days due to higher Q3 volumes. Net debt has been significantly reduced, improving the leverage ratio to 0.37x.
Key Highlights
Q3 FY26 Revenue up 35.7% YoY to ₹19,712 million; 9M FY26 Revenue up 29.2% to ₹51,686 million.
Adjusted PAT grew 23% YoY in Q3 to ₹3,229 million and 44.3% in 9M FY26 to ₹8,236 million.
New business and expansions won in Q3 FY26 represent $30.5 million in potential steady-state ACV.
Net Debt to Adjusted EBITDA ratio improved to 0.37x from 0.71x in FY25, with net debt at ₹6,426 million.
Total headcount reached 48,522 with over 4,100 clinicians and technology heads supporting growth.
💼 Action for Investors
The strong revenue momentum and margin stability make this a positive update, though investors should watch the working capital cycle given the rise in DSO to 86 days. The significant reduction in net debt and strong PAT growth are key positives for long-term valuation.